These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines. Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571 [TBL] [Abstract][Full Text] [Related]
29. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. Assoumou L; Charpentier C; Recordon-Pinson P; Grudé M; Pallier C; Morand-Joubert L; Fafi-Kremer S; Krivine A; Montes B; Ferré V; Bouvier-Alias M; Plantier JC; Izopet J; Trabaud MA; Yerly S; Dufayard J; Alloui C; Courdavault L; Le Guillou-Guillemette H; Maillard A; Amiel C; Vabret A; Roussel C; Vallet S; Guinard J; Mirand A; Beby-Defaux A; Barin F; Allardet-Servent A; Ait-Namane R; Wirden M; Delaugerre C; Calvez V; Chaix ML; Descamps D; Reigadas S; J Antimicrob Chemother; 2017 Jun; 72(6):1769-1773. PubMed ID: 28333232 [TBL] [Abstract][Full Text] [Related]
31. [Rate of genotypic mutations and resistance to antiretroviral drugs in a general hospital]. Fernández Lisón LC; Fernández Pereira LM; Romero Chala S Farm Hosp; 2011; 35(4):191-6. PubMed ID: 21087876 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586 [TBL] [Abstract][Full Text] [Related]
33. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089 [TBL] [Abstract][Full Text] [Related]
34. HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Puthanakit T; Jourdain G; Hongsiriwon S; Suntarattiwong P; Chokephaibulkit K; Sirisanthana V; Kosalaraksa P; Petdachai W; Hansudewechakul R; Siangphoe U; Suwanlerk T; Ananworanich J; HIV Med; 2010 Oct; 11(9):565-72. PubMed ID: 20345882 [TBL] [Abstract][Full Text] [Related]
36. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia. Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198 [TBL] [Abstract][Full Text] [Related]
37. Impact of the number of failed therapeutic regimes on the development of resistance mutations to HIV-1 in northeast Brazil. Medeiros MS; Arruda EA; Guerrant RL; Brown CC; Lima AA Braz J Infect Dis; 2007 Oct; 11(5):451-5. PubMed ID: 17962868 [TBL] [Abstract][Full Text] [Related]
38. Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy. de la Rosa R; Ruíz-Mateos E; Rubio A; Abad MA; Vallejo A; Rivero L; Genebat M; Sánchez-Quijano A; Lissen E; Leal M J Antimicrob Chemother; 2004 Jan; 53(1):95-101. PubMed ID: 14657091 [TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus type 1 infection in Oman: antiretroviral therapy and frequencies of drug resistance mutations. Al Dhahry SH; Scrimgeour EM; Al Suwaid AR; Al Lawati MR; El Khatim HS; Al Kobaisi MF; Merigan TC AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1166-72. PubMed ID: 15588338 [TBL] [Abstract][Full Text] [Related]
40. Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy. Lambert-Niclot S; Flandre P; Valantin MA; Peytavin G; Sayon S; Morand-Joubert L; Delaugerre C; Algarte-Genin M; Katlama C; Calvez V; Marcelin AG J Antimicrob Chemother; 2012 Jun; 67(6):1470-4. PubMed ID: 22396434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]